Articles

Sapien XT, FDA

The U.S. Food and Drug Administration (FDA) approval for its Edwards Sapien XT transcatheter aortic heart valve for the treatment of high-risk and inoperable patients suffering from severe...

Watchman, LAA occluder

Interventional thought leaders at the American College of Cardiology (ACC) 2014 meeting shared their predictions about the cutting-edge technologies emerging today that will become commonplace in...

Medtronic announced it is purchasing Covidien in a cash-and-stock deal for $42.9 billion. Once the transaction is completed, Medtronic will have significantly advanced its position as a premier...

Researchers at the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting (SNMMI) revealed how a protein encourages the production of stem cells that regenerate damaged tissues of...

Boston Scientific REPRISE II Clinical Trial Six-month Results Lotus Valve

Further validating its advanced transcatheter aortic valve implantation (TAVI) technology, the Boston Scientific Corp. Lotus Valve System continued to demonstrate impressive performance at six...

3-d pronting, 3D printing

The FDA has recognized 3-D printing technology now exists to print medical devices and is gathering information regarding technical assessments that should be considered when it will inevitably...

St. Jude Medical Portico TAVR System U.S. Implants Clinical Study

St. Jude Medical Inc. announced that the first patient implants occurred in the Portico Re-sheathable Transcatheter Aortic Valve System U.S. IDE Trial (PORTICO trial).

Corevalve, FDA, Edwards, TAVR, TAVI, lawsuit, injunction

In a surprise move, Edwards Lifesciences Corp. and Medtronic reached an agreement this week to settle all outstanding patent litigation between the companies, including cases related to...

American Heart Assn. Statement Babies Congenital Heart

Fetal heart experts working with the American Heart Assn. have developed guidelines to help healthcare providers care for unborn babies with heart problems, as well as their families.

FDA MSC Consortium Stem Cell Research

The U.S. Food and Drug Administration (FDA) MSC Consortium is a large team of FDA scientists studying adult mesenchymal stem cells (MSCs), which could eventually be used to repair, replace,...